Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB287877

Migfilin Antibody (OTI3G1), PerCP, Novus Biologicals™
SDP

Catalog No. NB287877 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB287877 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB287877 Supplier Novus Biologicals Supplier No. NBP272691PCP
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

Migfilin Monoclonal antibody specifically detects Migfilin in Human samples. It is validated for Western Blot

Specifications

Antigen Migfilin
Applications Western Blot
Classification Monoclonal
Clone OTI3G1
Conjugate PerCP
Dilution Western Blot
Formulation PBS
Gene Alias CAL, DKFZp434G171, FBLP-1FBLP1CSX-associated LIM, filamin binding LIM protein 1, filamin-binding LIM protein 1, filamin-binding LIM protein-1, MIG2-interacting protein, Migfilin, mitogen-inducible 2 interacting protein, Mitogen-inducible 2-interacting protein
Host Species Mouse
Immunogen Human recombinant protein fragment corresponding to amino acids 1-242 of human FBLIM1(NP_060026) produced in E.coli.
Purification Method Immunogen affinity purified
Quantity 0.1 mL
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 54751
Target Species Human
Content And Storage Store at 4C in the dark.
Form Purified
Isotype IgG1
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.